Back
Fennec Pharmaceuticals Vs. Bright Minds Biosciences Industry Stock Comparison
Buy
71
FRX.TO
Fennec Pharmaceuticals
Last Price:
8.62
Seasonality Move:
19.08%
Sell
38
DRUG.CX
Bright Minds Biosciences
Last Price:
55.51
Seasonality Move:
-19.1%
Buy
71
Fennec Pharmaceuticals (FRX.TO)
is a Buy
Is Fennec Pharmaceuticals a Buy, Sell or Hold?
- The current Fennec Pharmaceuticals [FRX.TO] share price is $8.62. The Score for FRX.TO is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- FRX.TO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Bright Minds Biosciences (DRUG.CX)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
- The current Bright Minds Biosciences [DRUG.CX] share price is $55.51. The Score for DRUG.CX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- DRUG.CX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FRX.TO Stock Price Chart
What is Fennec Pharmaceuticals's stock price today?
-
The Fennec Pharmaceuticals share price today is $8.62
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FRX.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRUG.CX Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $55.51
The current trend is relatively stagnant and DRUG.CX is experiencing buying pressure, which is a positive indicator for future bullish movement.
FRX.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.57 | Buy |
| Relative Strength Index (14 RSI): | 64.01 | Buy |
| Chaikin Money Flow: | 200 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
DRUG.CX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.8 | Buy |
| Relative Strength Index (14 RSI): | 50.43 | Buy |
| Chaikin Money Flow: | 340 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
FRX.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.52 | Buy |
| 20-day SMA: | 7.81 | Buy |
| 50-day SMA: | 6.84 | Buy |
| 200-day SMA: | 9.33 | Sell |
| 8-day EMA: | 8.49 | Buy |
| 20-day EMA: | 7.96 | Buy |
| 50-day EMA: | 7.38 | Buy |
| 200-day EMA: | 8.69 | Sell |
DRUG.CX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.9 | Sell |
| 20-day SMA: | 55.11 | Buy |
| 50-day SMA: | 51.69 | Buy |
| 200-day SMA: | 14.08 | Buy |
| 8-day EMA: | 55.7 | Sell |
| 20-day EMA: | 56.17 | Sell |
| 50-day EMA: | 48.25 | Buy |
| 200-day EMA: | 21.99 | Buy |
Fennec Pharmaceuticals Earnings Growth & FRX.TO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.30 per share.
Bright Minds Biosciences Earnings Growth & DRUG.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.53 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $4.02 per share.
Fennec Pharmaceuticals Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||